Evidence-Based Medicine Guidelines
Topiramate versus carbamazepine monotherapy for epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topiramate Versus Carbamazepine Monotherapy for Epilepsy." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy.
Topiramate versus carbamazepine monotherapy for epilepsy. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy. Accessed April 22, 2025.
Topiramate versus carbamazepine monotherapy for epilepsy. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy
Topiramate Versus Carbamazepine Monotherapy for Epilepsy [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topiramate versus carbamazepine monotherapy for epilepsy
ID - 1305063
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
